However, only an association between DNMT3B expression and drug sensitivity of cultured embryonal carcinoma cells11 has been reported to date, and no studies have examined the clinicopathological significance of DNMT3B expression in TGCT. Here, DNMT3B is linked to embryonal carcinoma.